21 a 21 Sep. 2022 - 09:30
As competition for research funding increases, funding agencies are looking for novel ways to allocate their funds in a bid to remove potential biases and increase the transparency of how funding decisions are made.
The overall goal of this event is to highlight examples from international funding entities that are either already piloting or considering implementing different models to allocate research funds, with a particular emphasis on the partial randomisation process, and highlight the perspective of researchers on this topic.
The session will end with a roundtable discussion featuring the views from researchers hosted by Portuguese institutions on whether partial randomisation is an appropriate alternative to the current peer review process.
Opening remarks, Champalimaud Foundation/Champalimaud Research
Marco Bieri, Scientific Officer, Swiss National Science Foundation
Lene Oddershede, Senior Vice President, Novo Nordisk Foundation
Axel Philipps, Leibniz Center for Science and Society, Leibniz University of Hannover
Adrian Mota, Associate Vice-President, Research Programs - Operations, Canadian Institutes of Health Research
Roundtable discussion: COLife Researchers views on partial randomisation for the allocation of research funding
Moderated by Adriana Sánchez-Danés, Champalimaud Foundation
Register here.
